Unknown

Dataset Information

Prediction of pyrazinamide resistance in Mycobacterium tuberculosis using structure-based machine-learning approaches.


ABSTRACT:

Background

Pyrazinamide is one of four first-line antibiotics used to treat tuberculosis; however, antibiotic susceptibility testing for pyrazinamide is challenging. Resistance to pyrazinamide is primarily driven by genetic variation in pncA, encoding an enzyme that converts pyrazinamide into its active form.

Methods

We curated a dataset of 664 non-redundant, missense amino acid mutations in PncA with associated high-confidence phenotypes from published studies and then trained three different machine-learning models to predict pyrazinamide resistance. All models had access to a range of protein structural-, chemical- and sequence-based features.

Results

The best model, a gradient-boosted decision tree, achieved a sensitivity of 80.2% and a specificity of 76.9%

SUBMITTER: Carter JJ 

PROVIDER: S-EPMC10946228 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature